220 U6
oct 24 2003 K 032 /
SECTION 9
510(k) SUMMARY
This 510(k) summary of safety and effectiveness for the Adept 1064/532 Laser is submitted in
accordance with the requirements of SMDA 1990 and follows Office of Device Evaluation
guidance concerning the organization and content of a 510(k) summary.
Applicant: Adept Medical Concepts, Inc.
Address: 29816 Avenue De Las Banderas :
Rancho Santa Margarita, CA 92688
Contact person: Mr. Jerry McFarland
President
jmcfarland@adeptmedicalconcepts.com
Telephone: 949-635-9238
949-635-9106 (fax)
Preparation Date: June 2003
(of the Summary)
Device Name: Adept 1064/532 Laser
Common Name: Surgical laser
Classification: Laser surgical instrument for use in general and plastic surgery and
dermatology
Class II medical device; (21 CFR 878.4810).
Product Code: GEX
Panel: 79
Predicate devices: The Depilase Twin YAG Laser (K020697);, Altus Family CoolGlide
Aesthetic Lasers (K014040, K003202, K023954, K022226, K981798);
Laserscope Lyra Surgical Laser System (K990903, K003765, K003147,
K010284, K010834, K020021).
Device description: The Adept 1064/532 is a long pulse Nd:YAG laser which emits its energy
at 1064 nm or 532 nm (frequency doubled wavelength).
Indications: The Adept 1064/532 Laser is indicated for coagulation and hemostasis of vascular
lesions (1064 and 532 nm wavelengths) and removal and permanent reduction of
OBO

ko32220 2¢

unwanted hair in Fitzpatrick skin types I - VI, including suntanned skin types (1064
nm wavelength). Permanent hair reduction is defined as a long-term stable
reduction in the number of hairs regrowing after a treatment regimen.

1064 nm

General Surgical Applications:

Incision, excision, coagulation, hemostasis, vaporization, and/or ablation of soft
tissue in dermatology/plastic surgery, endoscopic/laparoscopic general surgery,
gastroenterology, general surgery, gynecology, head and neck/-otorhinolaryngology
(ENT), neurosurgery, oculoplastics, orthopedics, pulmonary surgery, thoracic
surgery, and urology.
Dermatology/Plastic Surgery:

Coagulation and hemostasis of benign vascular lesions such as, but not limited to,
port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lake, leg and
spider veins. In addition, the Adept laser is intended for the treatment of benign
pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun
spots), café au lait macules, seborrheic keratoses, nevi chloasma, verrucae,
skin tags, keratoses, tattoos (significant reduction in the intensity of blue and/or
black tattoos) and plaques.

The Adept Laser is also indicated for pigmented lesions to reduce lesion size, for
patients with lesions that would potentially benefit from aggressive treatment, and
for patients with lesions that have not responded to other laser treatments.
Cutting, incision, excision, hemostasis, coagulation, vaporization, and ablation of
soft tissue in dermatology and plastic surgery.

The Adept Laser is also indicated for the treatment of facial wrinkles and wrinkles
such as, but not limited to, periocular and periorbital wrinkles.

The Adept Laser is indicated for the removal of unwanted hair, for the stable long
tem, or permanent, hair reduction through selective targeting of melanin in hair
follicles, and for the treatment for pseudofolliculitis barbae (PFB).

The Adept Laser is indicated for the reduction of red pigmentation in hypertrophic
and keloid scars where vascularity is an integral part of the scar.

The Adept Laser is indicated for use on all skin types (Fitzpatrick I - [V) including
tanned skin. and the removal and permanent reduction of unwanted hair in
Fitzpatrick skin types I - VI, including suntanned skin types (1064 nm wavelength).

061

K032220 3/6
Orthopedics:
Cutting, ablation, and/or hemostasis of intra-articular tissue in orthopedic surgical
and arthroscopic applications
Pulmonary Surgery:
Palliative treatment of benign and malignant pulmonary airway obstructions,
including squamous cell carcinoma, adenocarcinoma, carcinoid, benign tumors,
granulomas, and benign strictures.
Thoracic Surgery:
Cutting (incision/excision), coagulating, and vaporization of soft tissue. Thoracic
applications, including but not limited to, isolation of vessels for endarterectomy
and/or by-pass grafts, wedge resections, thoractomy, formation of pacemaker
pockets; vaporization, coagulation, incision/excision, debulking, and ablation of
lung tissue (thoracoscopy).
Urology:
All applications including superficial urinary bladder tumors, invasive bladder
carcinoma, urethral strictures and lesions of the external genitalia (including
condyloma acuminata).
532 nm
The Adept 1064/532 Laser is intended for the coagulation and hemostasis of
vascular lesions (1064 and 532 nm wavelengths).
For coagulation and hemostasis of vascular and cutaneous lesions in dermatology
including, but not limited to, the following general categories: vascular lesions
[angiomas, hemangiomas (port wine), telangiectasia (facial or extremities
telangiectasias, venous anomalies, leg veins]: benign pigmented lesions (nevi,
lentigines, chloasma, café au- lait, tattoos (red and green ink), verrucae, skin tags,
keratoses, plaques, cutaneous lesion treatment (hemostasis, color lightening,
blanching, flattening, reduction of lesion size.
General Surgery:
Vaporizing, Coagulating, Incising , Excising, Debulking, and Ablating of Soft
Tissue as well as in Endoscopic (e.g., laparoscopic) or open surgeries.

Ko32220 4/6
Endoscopic/Laparoscopic Surgery:
The Adept Laser is indicated for use in a variety of surgical procedures in several
surgical specialties. These include, but are not limited to, cholecystectomy,
appendectomy, vagotomy, and pyloromyomotomy where its abilities to incise,
excise, coagulate, vaporize, or ablate soft tissue may be applied.
General Surgery:
Incision, excision, vaporization, ablation, and hemostasis of soft tissue general
surgery applications, skin incisions, tissue dissection, excision of external tumors
and lesions, complete or partial resection of internal organs, tumors, lesions, tissue
ablation, vessel coagulation, tonsillectomy, and hemorrhoids.
Gynecology:
Treatment of menorrhagia by photocoagulation of the endometrial lining of the
uterus, ablation of endometrial implants and/or peritoneal adhesions, soft tissue
excisional procedures such as excisional conization of the cervix,
intrauterine gynecologic procedures where cutting, ablation, and/or vessel
coagulation may be indicated including submucous fibroids, benign endometrial
polyps, and uterine septum.
Head and Neck/-Otorhinolaryngology (ENT):
Tissue incision, excision, ablation, and vessel hemostasis.
Hemostasis During Surgery:
Adjunctive coagulation and hemostasis (bleeding control) during surgery in
endoscopic (e.g. laparoscopic) and open procedures.
Neurosurgery:
Hemostasis for pituitary tumor, meningioma, hemagioblastoma, AVMs.
glioblastoma, astrocytoma, oligodendroglioma.
Oculoplastics:
Incision, excision, vaporization, and/or coagulation of tissues in oculoplastic
procedures such as operations on the lacrimal system, operation on the eyelids,
removal of biopsy or orbital tumors, enucleation on eyeball, exteneration of orbital
contents.

Of3

Ko32220 5/6
Gastroenterology:
Tissue ablation and hemostasis in the gastrointestinal tract, Esophageal neoplastic
obstructions, including squamous cell carcinoma and adenocarcinoma,
Gastrointestinal hemostasis (including Varices, Esophagitis, Esophageal Ulcer,
Mallory-Weiss tear, Gastric Ulcer, Angiodysplasia, Stomal Ulcers, Non-bleeding
Ulcers, Gastric Erosions); Gastrointestinal Tissue ablation (Benign and Malignant
neoplasm, Angiodysplasia, Polyps, Ulcer, Colitis, Hemorrhoids).
Head and Neck/ Otorhinolaryngology (ENT):
Tissue incision, excision, ablation, and vessel hemostasis.
Hemostasis during Surgery;
Adjunctive coagulation and hemostasis (bleeding control) during surgery in
endoscopic (e.g., laparoscopic) and open surgery.
Neurosurgery:
Hemostasis for: Pituitary Tumor, Meningioma; hemagioblastoma; AVMs; Glioma;
Glioblastoma; Astrocytoma; Oligodendroglioma.
Incising, excising, coagulating, and vaporizing neurological tumors of the firm
textured type.
Ophthalmology:
Post-vitrectomy endophotocoagulation of the retina.
Spinal Surgery:
Percutaneous lumbar diskectomy.
Orthopedics:
Cutting, ablation, and/or hemostasis of intra-articular tissue in Orthopedic surgical
and arthroscopic applications.
Pulmonary Surgery:
Palliative treatment of benign and malignant pulmonary airway obstructions,
including Squamous Cell Carcinoma, Adenocarcinoma, Carcinoid; Benign Tumors;
Granulomas; Benign Strictures.

OR4

ko32220 ~—«/6
Thoracic Surgery:
Cutting (incision/excision), coagulating, and vaporizing of soft tissue. Thoracic
applications including, but not limited to: Isolation of vessels for endartecetomy
and/or by-pass grafts, Wedge Resections, Thoractomy, Formation of Pacemaker
pockets. Vaporization, coagulation, incision/excision, debulking, and ablation of
lung tissue (Thoracoscopy).
Urology:
All applications including: Superficial urinary bladder tumors, invasive bladder
carcinoma; Urethral Strictures, Lesions of the external genitalia (including
condyloma acuminata).
Performance Data: None required. The claim of substantial equivalence is based on comparisons
of specification/characteristics and intended uses of the Adept 1064/532 and
the claimed predicates.
Conclusion: Based on the information in the notification Adept Medical Concepts, Inc., believes
that the Adept 1064/532 Laser is substantially equivalent to the claimed
predicate(s) - see listing above.
ORS

es
f & DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
a
Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
OCT 24 2003
Mr. Jerry McFarland
President
Adept Medical Concepts, Inc.
29816 Avenue De Las Banderas
Rancho Santa Margarita, California 92688 /
Re: K032220
Trade/Device Name: Adept 1064/532 Laser
Regulation Number: 21 CFR 878.4810
: Regulation Name: Laser surgical instrument for use in general and .
plastic surgery and in dermatology
Regulatory Class: II oo
Product Code: GEX
Dated: July 17, 2003
Received: August 4, 2003
Dear Mr. McFarland:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug.
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions. against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class HI (PMA). it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as Sct
forth in the quality systems (QS) regulation (21 CFR Part 820): and if applicable. the electronic
product radiation control provisions (Sections 531-542 of the Act), 21 CFR 1000-1050.

|
Page 2 - Mr. Jerry McFarland This letter will allow you to begin marketing your device as described in your Section 51 0(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or

(301) 443-6597 or at its Internet address http://www. fda.gov/edrh/dsma/dsmamain.html :

Sincerely yours, “

, Nowa C Boveat

Celia M. Witten, Ph.D., M.D.

Director

Division of General, Restorative

and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure ‘ .

i
" Yo
SECTION 7 :
INDICATIONS FOR USE STATEMENT
510(k) Number (if known): K oD
Device Name: Adept 1064/532 Laser
Indications for Use Statement:
The Adept 1064/532 Laser is indicated for coagulation and haemostasis of vascular lesions (1064
and 532 nm wavelengths) and removal and permanent reduction of unwanted hair in Fitzpatrick
skin types I - VI, including suntanned skin types (1064 nm wavelength). Permanent hair reduction
is defined as a long-term stable reduction in the number of hairs regrowing after a treatment
regimen.
1064 nm wavelength :
General Surgical Applications:
For the incision, excision, coagulation, hemostasis, vaporization, and/or ablation of soft
tissue in dermatology/plastic surgery, endoscopic/laparoscopic general surgery,
gastroenterology, general surgery, gynecology, head and neck/otorhinolaryngology
(ENT), neurosurgery, oculoplastics, orthopedics, pulmonary surgery, thoracic surgery,
and urology.
Dermatology/Plastic Surgery:
For photocoagulation and hemostasis of benign vascular lesions such as, but not limited
to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lake, leg and
spider veins. In addition, the Adept Laser is intended for the treatment of benign,
pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun
spots). café au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags,
keratoses, tattoos (significant reduction in the intensity of blue and/or black tattoos) and
plaques. .
The Adept Laser is also indicated for pigmented lesions to reduce lesion size, for patients
with lesions that would potentially benefit from aggressive treatment, and for patients
with lesions that have not responded to other laser treatments.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation
Prescription Use _{ LT Yo u tofer-The Counter Use __
(Per 21 CFR 801.109) (Division Sign-Of)
Division of General, Restorative 053
and Neurological Devices
- (6 32220
$10(k) Sumber _K6 32220 ©

i
|
2f S

Cutting, incision, excision, hemostasis, coagulation, vaporization, and ablation of soft
tissue in dermatology and plastic surgery.
The Adept Laser is also indicated for the treatment of facial wrinkles and wrinkles such
as, but not limited to, periocular and periorbital wrinkles.
The Adept Laser is indicated for the removal of unwanted hair, for the stable long tem,
or permanent, hair reduction through selective targeting of melanin in hair follicles, and
for the treatment for pseudofolliculitis barbae (PFB).
The Adept Laser is indicated for the reduction of red pigmentation in hypertrophic and
keloid scars where vascularity is an integral part of the scar.
The Adept Laser is indicated for use on all skin types (Fitzpatrick I-IV) including tanned
skin. and the removal and permanent reduction of unwanted hair in Fitzpatrick skin types
I - VI, including suntanned skin types (1064 nm wavelength). .
Endoscopic/Laparoscopic Surgery:

The Adept Laser is indicated for use in a variety of surgical procedures in several surgical
specialties. These include, but are not limited to, cholecystectomy, appendectomy,
vagotomy, and pyloromyomotomy where its abilities to incise, excise, coagulate,
vaporize, or ablate soft tissue may be applied.

General Surgery:
For incision, excision, vaporization, ablation, and hemostasis of soft tissue general surgery
applications, skin incisions, tissue dissection, excision of external tumors and lesions,
complete or partial resection of internal organs, tumors, lesions, tissue ablation, vessel
coagulation, tonsillectomy, and hemorrhoids.
Gynecology:
For the treatment of menorrhagia by photocoagulation of the endometrial lining of the
uterus, ablation of endometrial implants and/or peritoneal adhesions, soft tissue excisional
procedures such as excisional conization of the cervix, intrauterine gynecologic
procedures where cutting, ablation, and/or vessel coagulation may be indicated including
submucous fibroids, benign endometrial polyps, and uterine septum.
Head and Neck/-Otorhinolaryngology (ENT):
For tissue incision, excision, ablation, and vessel hemostasis.

or

.
! 3/5
Hemostasis During Surgery: . For adjunctive coagulation and hemostasis (bleeding control) during surgery in
endoscopic (e.g. laparoscopic) and open procedures.
Neurosurgery:
For hemostasis for pituitary tumor, meningioma, hemagioblastoma, AVMs. glioblastoma,
astrocytoma, oligodendroglioma.
Oculoplastics:
For incision, excision, vaporization, and/or coagulation of tissues in oculoplastic
procedures such as operations on the lacrimal system, operation on the eyelids, removal
of biopsy or orbital tumors, enucleation on eyeball, exteneration of orbital contents.
Pulmonary Surgery:
For palliative treatment of benign and malignant pulmonary airway obstructions, including
squamous cell carcinoma, adenocarcinoma, carcinoid, benign tumors, granulomas, and
benign strictures.
Thoracic Surgery:
For cutting (incision/excision), coagulating, and vaporization of soft tissue. Thoracic
applications, including but not limited to, isolation of vessels for endarterectomy and/or
by-pass grafts, wedge resections, thoractomy, formation of pacemaker pockets;
vaporization, coagulation, incision/excision, debulking, and ablation of lung tissue
(thoracoscopy). : :
Urology:
For all applications including superficial urinary bladder tumors, invasive bladder
carcinoma, urethral strictures and lesions of the external genitalia (including condyloma
acuminata).
Orthopedics:
For cutting, ablation, and/or hemostasis of intra-articular tissue in orthopedic surgical and
arthroscopic applications.
532 nm wavelength
The Adept 1064/532 Laser is intended for the coagulation and hemostasis of vascular
lesions (1064 and 532 nm wavelengths).
gO!

4/5

Dermatology/Plastic Surgery: .
For photocoagulation and hemostasis of vascular and cutaneous lesions in dermatology
including, but not limited to, the following general categories: vascular lesions [angiomas,
hemangiomas (port wine), telangiectasia (facial or extremities telangiectasias, venous
anomalies, leg veins]: benign pigmented lesions (nevi, lentigines, chloasma, café au- lait,
tattoos (red and green ink), verrucae, skin tags, keratoses, plaques, cutaneous lesion
treatment (hemostasis, color lightening, blanching, flattening, reduction of lesion size.
General Surgery:
Vaporizing, Coagulating, Incising , Excising, Debulking, and Ablating of Soft Tissue as
well as in Endoscopic (e.g., laparoscopic) or open surgeries.
Gastroenterology: :
Tissue ablation and hemostasis in the gastrointestinal tract; Esophageal neoplastic
obstructions, including squamous cell carcinoma and adenocarcinoma, Gastrointestinal
hemostasis (including Varices, Esophagitis, Esophageal Ulcer, Mallory-Weiss tear,
Gastric Ulcer, Angiodysplasia, Stomal Ulcers, Non-bleeding Ulcers, Gastric Erosions);
Gastrointestinal Tissue ablation (Benign and Malignant neoplasm, Angiodysplasia, Polyps,
Ulcer, Colitis, Hemorrhoids).
Head and Neck Otorhinolaryngology (ENT):
Tissue incision, excision, ablation, and vessel hemostasis.
Hemostasis during Surgery:
Adjunctive coagulation and hemostasis (bleeding control) during surgery in endoscopic
(e.g., laparoscopic) and open surgery..
Neurosurgery: Hemostasis for. Pituitary Tumor, Meningioma; hemagioblastoma; AVMs; Glioma;
Glioblastoma; Astrocytoma; Oligodendroglioma.

. Ophthalmology:
Post-vitrectomy endophotocoagulation of the retina.
Pulmonary Surgery:
Palliative treatment of benign and malignant — pulmonary airway obstructions,
including Squamous Cell Carcinoma, Adenocarcinoma; Carcinoid; Benign Tumors;
Granulomas; Benign Strictures.

05

2 s/s
Thoracic Surgery: .
Cutting (incision/excision), coagulating, and vaporizing of soft tissue. Thoracic
applications including, but not limited to: Isolation of vessels for endartecetomy and/or
by-pass grafts, Wedge Resections, Thoractomy, Formation of Pacemaker pockets.
Vaporization, coagulation, incision/excision, debulking, and ablation of lung tissue
(Thoracoscopy).
Urology:
All applications including: Superficial urinary bladder tumors, invasive bladder
carcinoma; Urethral Strictures; Lesions of the external genitalia (including condyloma
acuminata).

05

